Omada Health, Inc. Common Stock
OMDAOmada Health is a virtual-first healthcare provider that delivers long-term behavior change programs for chronic conditions including diabetes, hypertension, and musculoskeletal issues.
Earnings
Next report
Aug 6, 2026 (in a month)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Omada Health is a virtual-first healthcare provider that delivers long-term behavior change programs for chronic conditions including diabetes, hypertension, and musculoskeletal issues. The company utilizes a human-led, technology-enabled care model called Compassionate Intelligence to provide personalized support between traditional doctor visits. Its value proposition centers on improving clinical outcomes and reducing healthcare costs for employers, health plans, and pharmacy benefit managers.
Omada differentiates itself through a multi-condition platform grounded in peer-reviewed clinical research and a human-led coaching model enhanced by proprietary AI.
Questions, answered.
- What is Omada Health, Inc. Common Stock's market cap?
- Omada Health, Inc. Common Stock (OMDA) has a market capitalization of $1.1B and trades on NASDAQ.
- What is Omada Health, Inc. Common Stock's revenue and profitability?
- Omada Health, Inc. Common Stock generated $283.3M in trailing twelve-month revenue with a net loss of $20.9M, representing a net margin of -11.3%. Gross margin stands at 66.3%, with free cash flow of -$13.8M. These figures are based on the Q1 2026 filing.
- Who are Omada Health, Inc. Common Stock's competitors?
- Omada Health, Inc. Common Stock's key competitors include Teladoc Health, Inc., DarioHealth Corp., Viking Therapeutics, Inc, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Omada Health, Inc. Common Stock have?
- Omada Health, Inc. Common Stock's subsidiaries include Physera Physical Therapy Group, PC.
- Where is Omada Health, Inc. Common Stock headquartered?
- Omada Health, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.
